WebDec 22, 2014 · Cubist Pharmaceuticals, Inc. INVESTORS: Eileen C. McIntyre, 781-860-8533 Vice President, Investor Relations [email protected] or MEDIA: Jennifer Baird, 781-860-1282 Director, Product Communications [email protected] Help employers find you! Check out all the jobs and post your resume. WebCubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called …
Merck to buy Cubist Pharmaceuticals for $9.5 billion - CNBC
WebJul 11, 2024 · 12% of Cubist Pharmaceuticals employees are Hispanic or Latino. The average employee at Cubist Pharmaceuticals makes $91,725 per year. Cubist Pharmaceuticals employees are most likely to be members of the democratic party. On average, employees at Cubist Pharmaceuticals stay with the company for 3.8 years. WebDec 18, 2015 · It was a Sunday in early December of last year, and Mike Bonney was sitting in his home-away-from-home — the Lexington boardroom of Cubist Pharmaceuticals. The CEO was contemplating his coming ... bipartisan coffee
Jennifer Baird - Executive Director, Corporate Communications ...
WebSee all 51 Cubist Pharmaceuticals salaries 11 Clinical Business Managers from Cubist Pharmaceuticals submitted salaries. $126K Senior Manager $50K IP Patent Paralegal … Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion). WebJan 21, 2015 · Cubist’s stockholders who are entitled to and properly exercise appraisal rights under Delaware law, will be canceled and converted into the right to receive cash … bipartisan chips and science act of 2022